$119.99
Research Studies:
Out of stock
FREE Shipping on
orders over $200
ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. The products offered on this website are intended solely for research and laboratory use. These products are not intended for human or animal consumption. They are not medicines or drugs and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. Any form of bodily introduction is strictly prohibited by law.
Thymosin Alpha-1 10mg is a research-use-only laboratory material supplied for controlled research workflows, compound characterization, and analytical documentation review. It is manufactured under rigorous quality standards to support consistency, traceability, and batch-specific verification for qualified laboratory settings.
Thymosin Alpha-1 10mg is intended strictly for laboratory research use only. This product is not intended for human or animal consumption, therapeutic use, diagnostic use, clinical use, veterinary use, or as a food, drug, cosmetic, dietary supplement, or household product.
| CAS No. | 62304-98-7 |
|---|---|
| Purity | ≥99% |
| Sequence | Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn |
| Molecular Formula | C129H215N33O55 |
| Molecular Weight | 3108.3 g/mol |
| Applications | Immunology research, viral infection models, cancer immunotherapy studies |
| Synthesis | Solid-phase synthesis |
| Solubility | Soluble in water or 1% acetic acid |
| Stability & Storage | Stable for up to 24 months at -20°C. After reconstitution, may be stored at 4°C for up to 4 weeks or at -20°C for up to 6 months. |
| Appearance | White lyophilized powder |
| Shipping Conditions | Shipped at ambient temperature; once received, store at -20°C |
| Regulatory/Compliance | Manufactured in a facility that adheres to cGMP guidelines |
| Safety Information | Refer to provided MSDS |
Consider these supplementary peptides for a comprehensive research approach.
Researchers searching for buy Thymosin Alpha-1 online should evaluate Thymosin Alpha-1 as a research-use-only laboratory material, not a consumer product. For laboratory buyers, the key considerations are compound identity, purity documentation, batch-specific COAs, lot traceability, product labeling, and storage information. This guide explains how to evaluate Thymosin Alpha-1 for controlled research procurement through Pure Lab Peptides, with emphasis on documentation review, supplier transparency, and research-use-only boundaries.
Researchers can buy Thymosin Alpha-1 online for laboratory research by reviewing RUO labeling, batch-specific COA documentation, purity data, identity information, storage guidance, and supplier transparency before selecting a source. Products discussed in this article are intended for laboratory research use only and are not intended for human or animal consumption.
The phrase `buy Thymosin Alpha-1 online` is addressed here as laboratory research procurement intent, not personal-use intent. In this context, procurement teams are not evaluating Thymosin Alpha-1 as a wellness item, clinical item, or consumer peptide. They are evaluating whether a research-use-only material is labeled appropriately, supported by documentation, and traceable to a specific batch.
RUO sourcing starts with the intended-use statement. FDA guidance on research-use-only and investigational-use-only labeling for certain laboratory products emphasizes that RUO labeling is tied to research settings rather than diagnostic use [1]. For peptide procurement, the same practical principle applies: the supplier should keep the product positioned as a laboratory research material and avoid personal-use framing.
A qualified laboratory buyer should review the Thymosin Alpha-1 COA, the lot number, the product name, the product form, the purity statement, and the analytical method before documenting the purchase. Supplier transparency also matters. A credible research supplier makes Thymosin Alpha-1 supplier documentation easy to locate, keeps the RUO boundary clear, and does not substitute marketing claims for analytical documentation.
Thymosin Alpha-1 is commonly discussed in scientific literature as a thymic peptide, and the chemically synthesized version is identified as thymalfasin. PubChem lists thymalfasin with molecular formula C129H215N33O55 and identifies it as a synthetic version of Thymosin Alpha-1 [2]. The National Cancer Institute describes thymalfasin as a synthetic analogue of Thymosin Alpha-1 and notes its relationship to the precursor protein prothymosin alpha [3].
The original biochemical literature characterized Thymosin Alpha-1 as a heat-stable, acidic 28-amino-acid peptide from thymosin fraction 5 [4]. Later sequence-oriented work further described the chemistry of alpha thymosins and the amino acid sequence of Thymosin Alpha-1 [5]. UniProt records prothymosin alpha as the human precursor entry, while ChEMBL lists thymalfasin as CHEMBL2103979 for database-level compound identification [6] [7].
Published reviews describe Thymosin Alpha-1 in immunology and peptide research contexts, including biochemical production, pathway literature, and broader review-based evidence [8] [9] [10]. Cellular-model papers have also examined dendritic-cell and Toll-like-receptor signaling contexts, but those findings are scientific context only and are not product-use instructions for RUO materials [11] [12] [13] [14].
For procurement purposes, Thymosin Alpha-1 research material should be evaluated through identity testing, purity documentation, and batch records rather than expected outcomes. Short peptide research literature should be discussed as scientific context, not as product-use guidance.
Researchers and technical procurement teams search this phrase because online sourcing can make product documentation visible before a purchase decision. A laboratory buyer may need to compare RUO product availability, verify that Thymosin Alpha-1 research-use-only positioning is clear, and determine whether batch-specific documentation is available before adding a material to internal purchasing records.
When a team searches buy Thymosin Alpha-1, the priority should not be promotional language. The priority should be evidence of compound identity, lot-level traceability, Thymosin Alpha-1 purity documentation, and a COA that matches the product being evaluated. Product-form details also matter because a lyophilized powder should be documented in records alongside supplier handling information and storage guidance.
Search intent can also reflect supplier comparison. A laboratory buyer may compare whether product pages provide a clear product name, amount, purity claim, research-use-only statement, and access to batch-specific COA documentation. Those procurement signals are more relevant to controlled research purchasing than broad claims about pathways, outcomes, or consumer uses.
Researchers evaluating where to buy Thymosin Alpha-1 online should review quality signals together, not as isolated claims. HPLC is widely used in peptide analysis and purification, while mass spectrometry is commonly used to support peptide identity and purity assessment in synthetic peptide workflows [15] [16] [17] [18].
| Quality signal | What researchers should review | Why it matters for RUO procurement |
| RUO labeling | Clear research-use-only statement on the product page and documentation | Shows that the supplier is framing the material for controlled laboratory procurement |
| Batch-specific COA | Product name, lot number, purity value, method, and test date | Links analytical documentation to the exact material under review |
| Identity testing | Mass spectrometry, LC-MS, or equivalent identity information | Supports confirmation that the documented material matches Thymosin Alpha-1 |
| Purity documentation | HPLC or comparable chromatographic data | Helps researchers assess the reported purity claim in context |
| Lot traceability | Lot number consistency across label, COA, and internal records | Allows procurement and laboratory teams to connect records to a specific batch |
| Supplier documentation | Storage guidance, product form, and clear product details | Supports internal documentation without shifting into product-use guidance |
A Thymosin Alpha-1 COA should be reviewed as a batch-specific analytical record. Researchers should look for the compound name, lot number, test date, purity percentage, testing method, identity confirmation, molecular weight where relevant, sequence information where relevant, chromatogram or mass data where available, product form, and storage documentation.
A purity percentage alone does not establish complete compound identity; researchers should evaluate purity, identity, method, lot number, and documentation together. LC-HRMS literature on peptide impurities illustrates why structurally related peptide materials may require more than a simple purity value, and chiral HPLC-MS/MS literature shows that specialized methods can be relevant for certain peptide quality questions [19] [20]. ICH Q2(R2) provides a general framework for analytical-procedure validation concepts, and ISO/IEC 17025 describes competence expectations for testing and calibration laboratories [21] [22].
For Thymosin Alpha-1 identity testing, the strongest procurement file is the one that keeps label, COA, product page, and internal receiving record aligned. If the lot number or product name differs across documents, the discrepancy should be resolved before the material is entered into a controlled research workflow.
Published literature has examined Thymosin Alpha-1 in biochemical, immunology, cellular-model, review-based, and clinical study settings. Database records identify thymalfasin and prothymosin-alpha relationships, while early biochemical papers describe isolation and sequence characterization [2] [4] [5]. Review articles summarize broader research areas, but review conclusions should not be converted into claims about RUO materials [8] [9] [10].
Cellular-model studies have investigated dendritic-cell differentiation and Toll-like-receptor-linked signaling models involving Thymosin Alpha-1 [11] [12] [13] [14]. Those publications are useful for understanding why the compound appears in immunology research literature, but they do not establish procurement criteria beyond identity, documentation, and analytical review.
Published clinical literature should not be interpreted as use guidance for RUO materials. The presence of clinical or translational papers in a database does not change the status of a research-use-only compound sold for laboratory research procurement. For this article, the literature context is used only to support compound identification and scientific background, not to recommend use, preparation, administration, or outcomes.
| Evidence type | Examples for Thymosin Alpha-1 | Procurement interpretation |
| Database records | PubChem, ChEMBL, UniProt, and NCI records identify thymalfasin, prothymosin alpha, and related naming conventions [2] [7] | Useful for identity cross-checking and terminology, not a substitute for a batch-specific COA |
| Original characterization literature | Early papers describe isolation, sequence analysis, and chemical characterization [4] [5] | Supports neutral background on compound identity |
| Review literature | Reviews summarize biochemical production and research areas involving Thymosin Alpha-1 [8] [9] | Helpful for scientific context, but not product-use guidance |
| Cellular-model literature | Studies discuss dendritic-cell and Toll-like-receptor signaling models [11] [13] | Context for research interest, not a procurement claim or protocol |
| Analytical-method literature | HPLC, LC-MS, mass spectrometry, impurity, and chiral purity literature describes methods relevant to peptide quality review [15] [18] [19] | Supports COA interpretation and documentation review |
| Acceptable research phrasing | Unsafe product-claim phrasing |
| “Thymosin Alpha-1 appears in peptide and immunology research literature.” | “Thymosin Alpha-1 produces wellness or therapeutic outcomes.” |
| “Review the batch-specific Thymosin Alpha-1 COA before procurement.” | “A purity percentage alone proves the material is suitable for any intended outcome.” |
| “Evaluate HPLC, LC-MS, or mass spectrometry information where documented.” | “Analytical documentation can be replaced by reviews, testimonials, or expected results.” |
| “Thymosin Alpha-1 research-use-only materials should remain in controlled laboratory contexts.” | “RUO labeling supports personal, clinical, veterinary, or consumer use.” |
| “Published literature is scientific background for qualified researchers.” | “Published literature provides product-use guidance for RUO materials.” |
Pure Lab Peptides presents Thymosin Alpha-1 10mg as a research-use-only compound. The fixed product attributes for this research-procurement guide are a ≥99% purity claim, lyophilized powder form, and batch-specific COA availability. Researchers should review the product page and batch-specific documentation to confirm the product name, lot information, product form, storage and handling documentation, and analytical details before procurement.
Review the Pure Lab Peptides Thymosin Alpha-1 research-use-only product page for RUO labeling, product details, purity information, and batch-specific documentation. Laboratory teams comparing broader peptide options can also review the research peptide collection, the blog resource area, and shipping and returns information for supplier documentation context.
Pure Lab Peptides documentation should be treated as a procurement record, not as a protocol. Lot-level traceability, Thymosin Alpha-1 supplier documentation, storage and handling information, and the available batch-specific COA are the central quality signals for qualified research buyers.
In this article, the phrase means laboratory research procurement only. A qualified buyer is evaluating RUO labeling, COA availability, identity testing, and supplier transparency. The article does not address personal-use selection, self-directed use, or non-laboratory purchasing decisions.
Published research can explain why a compound appears in scientific databases or research literature. It does not turn an RUO material into a clinical, diagnostic, veterinary, or consumer product. Short peptide research literature should be discussed as scientific context, not as product-use guidance.
Purity is one documentation element, not the entire identity record. Researchers should assess Thymosin Alpha-1 purity documentation together with analytical method, mass or sequence confirmation where available, lot number, product name, test date, and supplier documentation.
A general sample COA is less useful than a batch-specific COA tied to the lot under review. Procurement teams should confirm that the label, COA, product page, and receiving record all reference the same Thymosin Alpha-1 material and lot identifier.
Thymosin Alpha-1 appears in pathway and immunology literature, but pathway relevance is not a product claim for an RUO material. Procurement language should stay focused on identity, purity, analytical documentation, labeling, traceability, and storage records.
Researchers can buy Thymosin Alpha-1 online for laboratory research from an RUO supplier that provides clear labeling, product details, batch-specific COA access, purity documentation, and identity information. Pure Lab Peptides provides a Thymosin Alpha-1 10mg product page for research procurement review.
Before buying Thymosin Alpha-1 online, researchers should check RUO labeling, the batch-specific COA, the reported purity, identity testing, product form, lot number consistency, storage information, and supplier documentation. The review should remain focused on laboratory procurement rather than product-use expectations.
A COA matters when buying Thymosin Alpha-1 because it connects analytical documentation to a specific batch. A strong COA review looks at product name, lot number, method, purity value, identity confirmation, and test date together, rather than relying on a purity statement alone.
Thymosin Alpha-1 discussed here is not intended for human or animal consumption. It is addressed as a research-use-only laboratory material for qualified researchers, laboratory buyers, research institutions, and technical procurement teams evaluating documentation and supplier transparency.
Research use only means Thymosin Alpha-1 is positioned for controlled laboratory research contexts and not for clinical, diagnostic, veterinary, or consumer use. For procurement teams, RUO review centers on labeling, COA availability, purity documentation, identity information, and lot-level traceability.
Published literature about Thymosin Alpha-1 should be interpreted as scientific background, not product-use guidance for RUO materials. Literature may describe compound identity, cellular models, pathway research, or clinical study settings, but procurement decisions should focus on documentation, labeling, and analytical review.
Qualified researchers evaluating Thymosin Alpha-1 should review product labeling, COA status, identity documentation, storage information, and supplier transparency before selecting any research-use-only material. Review the Thymosin Alpha-1 product page for RUO labeling, purity information, and available batch-specific documentation.
Our team is ready to assist you with any inquiries regarding our catalogue of peptides and their applications.
Discount Applied Successfully!
Your savings have been added to the cart.
There are no reviews yet.